Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 NICE guideline: attention deficit hyperactivity disorder.

× No keyword cloud information.

19 in total

Review 1. The pharmacology of amphetamine and methylphenidate: Relevance to the neurobiology of attention-deficit/hyperactivity disorder and other psychiatric comorbidities.

Authors: Stephen V Faraone
Journal: Neurosci Biobehav Rev Date: 2018-02-08 Impact factor: 8.989

2. One-year prospective follow-up of pharmacological treatment in children with attention-deficit/hyperactivity disorder.

Authors: Anna Didoni; Marco Sequi; Pietro Panei; Maurizio Bonati
Journal: Eur J Clin Pharmacol Date: 2011-05-03 Impact factor: 2.953

3. Differences in ADHD medication usage patterns in children and adolescents from different cultural backgrounds in the Netherlands.

Authors: Els F van den Ban; Patrick C Souverein; Herman van Engeland; Hanna Swaab; Toine C G Egberts; Eibert R Heerdink
Journal: Soc Psychiatry Psychiatr Epidemiol Date: 2015-05-28 Impact factor: 4.328

Review 4. Drug Treatment of Epilepsy Neuropsychiatric Comorbidities in Children.

Authors: Gregory L Holmes
Journal: Paediatr Drugs Date: 2020-11-24 Impact factor: 3.022

5. Social-skills and parental training plus standard treatment versus standard treatment for children with ADHD--the randomised SOSTRA trial.

Authors: Ole Jakob Storebø; Christian Gluud; Per Winkel; Erik Simonsen
Journal: PLoS One Date: 2012-06-20 Impact factor: 3.240

6. The challenges of implementing ADHD clinical guidelines and research best evidence in routine clinical care settings: Delphi survey and mixed-methods study.

Authors: Charlotte L Hall; John A Taylor; Karen Newell; Laurence Baldwin; Kapil Sayal; Chris Hollis
Journal: BJPsych Open Date: 2016-01-20

7. Predicting acute side effects of stimulant medication in pediatric attention deficit/hyperactivity disorder: data from quantitative electroencephalography, event-related potentials, and a continuous-performance test.

Authors: Geir Ogrim; Knut A Hestad; Jan Ferenc Brunner; Juri Kropotov
Journal: Neuropsychiatr Dis Treat Date: 2013-09-05 Impact factor: 2.570

8. Prefrontal activation during inhibitory control measured by near-infrared spectroscopy for differentiating between autism spectrum disorders and attention deficit hyperactivity disorder in adults.

Authors: Ayaka Ishii-Takahashi; Ryu Takizawa; Yukika Nishimura; Yuki Kawakubo; Hitoshi Kuwabara; Junko Matsubayashi; Kasumi Hamada; Shiho Okuhata; Noriaki Yahata; Takashi Igarashi; Shingo Kawasaki; Hidenori Yamasue; Nobumasa Kato; Kiyoto Kasai; Yukiko Kano
Journal: Neuroimage Clin Date: 2013-10-26 Impact factor: 4.881

9. Concomitant pharmacotherapy of psychotropic medications in EU children and adolescents with attention-deficit/hyperactivity disorder.

Authors: Vanja Sikirica; Moshe Fridman; Amanda Bruno; Paul Hodgkins; M Haim Erder
Journal: Drugs R D Date: 2013-12

Review 10. Why the Diagnosis of Attention Deficit Hyperactivity Disorder Matters.

Authors: Alaa M Hamed; Aaron J Kauer; Hanna E Stevens
Journal: Front Psychiatry Date: 2015-11-26 Impact factor: 4.157